Deborah J. Kissire
Deborah J. Kissire's purchase track record
Deborah J. Kissire has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/7/2025 | CE | $54K | +0.3% | -11.8% | +12.3% |
| 9/13/2023 | AXTA | $11K | +24.1% | +25.8% | +15.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
S&P Downgrades Cable One to B+ Amid Weakening Broadband Outlook. S&P Global downgraded Cable One to B+ after noting a weaker broadband outlook. The rating reflects concerns about the company’s growth prospects in the telecom market. The downgrade may affect investor perception as the stock trades near its 52‑week low. The move comes while the broader sector sees pressure, as seen in Charter Communications’ recent decline.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Celanese Sets Q3 Earnings Call for November 3, 2026. Celanese has announced it will hold its third-quarter earnings conference call on November 3, 2026. The company is also mentioned in a new industry report on thermo compression forming, which highlights its role in advanced manufacturing. With the stock trading near its 52-week low, upcoming earnings results may provide clarity on the company's performance.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
UBS Cuts Axalta Price Target to $36, Maintains Neutral Rating. UBS lowered its price target for Axalta to $36 while keeping a neutral stance. The company also announced the date for its third-quarter 2026 earnings call. These updates provide new context as Axalta trades near its 52-week low, with the stock currently sitting above a key support level.
Transaction History
| OMC | ▲ Buy | Grant | 696 | $0 | 10/1/2026 | View on chart |
| OMC | ▲ Buy | Grant | 704 | $0 | 7/1/2026 | View on chart |
| CABO | ▲ Buy | Grant | 3,031 | $155K | 5/14/2026 | View on chart |
| CE | ▲ Buy | Grant | 2,975 | $0 | 5/11/2026 | View on chart |
| CE | ▼ Sell | Other | 3,376 | — | 5/9/2026 | View on chart |
| OMC | ▲ Buy | Grant | 681 | $0 | 4/1/2026 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 5,832 | — | 3/4/2026 | View on chart |
| OMC | ▲ Buy | Grant | 635 | $0 | 1/1/2026 | View on chart |
| OMC | ▲ Buy | Grant | 629 | $0 | 10/1/2025 | View on chart |
| OMC | ▲ Buy | Grant | 712 | $0 | 7/1/2025 | View on chart |
| CE | ▼ Sell | Other | 1,114 | — | 5/15/2025 | View on chart |
| CABO | ▲ Buy | Grant | 941 | $155K | 5/15/2025 | View on chart |
| CE | ▲ Buy | Grant | 3,376 | $0 | 5/9/2025 | View on chart |
| OMC | ▲ Buy | Grant | 618 | $0 | 4/1/2025 | View on chart |
| CE | ▲ Buy | Open Market | 1,000 | $54K | 3/7/2025 | View on chart |
| CABO | ▲ Buy | Grant | 8 | $2K | 3/7/2025 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,157 | — | 2/28/2025 | View on chart |
| OMC | ▲ Buy | Grant | 596 | $0 | 1/1/2025 | View on chart |
| CABO | ▲ Buy | Grant | 6 | $2K | 12/20/2024 | View on chart |
| OMC | ▲ Buy | Grant | 423 | $0 | 10/1/2024 | View on chart |
| CABO | ▲ Buy | Grant | 7 | $2K | 9/13/2024 | View on chart |
| OMC | ▲ Buy | Grant | 488 | $0 | 7/1/2024 | View on chart |
| CABO | ▲ Buy | Grant | 6 | $2K | 6/14/2024 | View on chart |
| CABO | ▲ Buy | Grant | 392 | $155K | 5/16/2024 | View on chart |
| CE | ▲ Buy | Grant | 1,114 | $175K | 5/15/2024 | View on chart |
| CE | ▼ Sell | Other | 1,777 | — | 5/12/2024 | View on chart |
| OMC | ▲ Buy | Grant | 452 | $0 | 4/1/2024 | View on chart |
| CABO | ▲ Buy | Grant | 5 | $2K | 3/8/2024 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,711 | — | 2/28/2024 | View on chart |
| OMC | ▲ Buy | Grant | 506 | $0 | 1/1/2024 | View on chart |
| CABO | ▲ Buy | Grant | 3 | $0 | 12/15/2023 | View on chart |
| OMC | ▲ Buy | Grant | 587 | $0 | 10/1/2023 | View on chart |
| CABO | ▲ Buy | Grant | 3 | $0 | 9/15/2023 | View on chart |
| AXTA | ▲ Buy | Open Market | 400 | $11K | 9/13/2023 | View on chart |
| OMC | ▲ Buy | Grant | 460 | $0 | 7/1/2023 | View on chart |
| CABO | ▲ Buy | Grant | 3 | $0 | 6/16/2023 | View on chart |
| CABO | ▲ Buy | Grant | 233 | $155K | 5/19/2023 | View on chart |
| CE | ▲ Buy | Grant | 1,777 | $175K | 5/12/2023 | View on chart |
| CE | ▼ Sell | Other | 1,098 | — | 5/3/2023 | View on chart |
| OMC | ▲ Buy | Grant | 464 | $0 | 4/1/2023 | View on chart |
| CABO | ▲ Buy | Grant | 3 | $0 | 3/10/2023 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 6,939 | — | 2/15/2023 | View on chart |
| OMC | ▲ Buy | Grant | 536 | $0 | 1/1/2023 | View on chart |
| CABO | ▲ Buy | Grant | 2 | $0 | 12/16/2022 | View on chart |
| OMC | ▲ Buy | Grant | 693 | $0 | 10/1/2022 | View on chart |
| CABO | ▲ Buy | Grant | 1 | $0 | 9/16/2022 | View on chart |
| OMC | ▲ Buy | Grant | 688 | $0 | 7/1/2022 | View on chart |
| CABO | ▲ Buy | Grant | 1 | $0 | 6/17/2022 | View on chart |
| CABO | ▲ Buy | Grant | 130 | $0 | 5/20/2022 | View on chart |
| CE | ▲ Buy | Grant | 1,098 | $160K | 5/3/2022 | View on chart |
| CE | ▼ Sell | Other | 975 | — | 4/27/2022 | View on chart |
| OMC | ▲ Buy | Grant | 515 | $0 | 4/1/2022 | View on chart |
| AXTA | ▲ Buy | Option Exercise | 7,208 | — | 3/3/2022 | View on chart |
| OMC | ▲ Buy | Grant | 597 | $0 | 1/1/2022 | View on chart |
| OMC | ▲ Buy | Grant | 604 | $0 | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Omnicom Announces Q3 2026 Earnings Call and Highlights AI Strategy
Omnicom Group has set a date for its third‑quarter 2026 earnings release and conference call, signaling a new reporting cycle. The company’s leadership, including CEO Christine Gambino and CFO Ben Hovaness, has emphasized the importance of AI and data for unified brand responses. Analysts note that the firm may be undervalued by about 23% following the finance leadership change, and its cash‑flow value suggests a reasonable stock price. These developments suggest a focus on technology and financial positioning as Omnicom prepares for the upcoming earnings.
Omnicom Announces Q3 2026 Earnings Call and Highlights AI Strategy. Omnicom Group has set a date for its third‑quarter 2026 earnings release and conference call, signaling a new reporting cycle. The company’s leadership, including CEO Christine Gambino and CFO Ben Hovaness, has emphasized the importance of AI and data for unified brand responses. Analysts note that the firm may be undervalued by about 23% following the finance leadership change, and its cash‑flow value suggests a reasonable stock price. These developments suggest a focus on technology and financial positioning as Omnicom prepares for the upcoming earnings.